Who owns DSCM?
sec.gov
Shares Beneficially Owned
After this Offering(1)(2)
----------------------------------------------------------------
Beneficial Owner Number Percentage
------------------------------------ ----------------- ------------------------------- --------------
<S> <C> <C>
Amazon.com, Inc.(1) 11,733,523 ...... 27.4%
1516 2nd Avenue
Seattle, WA 98101
Rite Aid Corporation(2)... 9,334,746 ...... 21.8%
30 Hunter Lane
Camp Hill, PA 17011
Kleiner Perkins Caufield &
Byers(3)................. 7,030,771 ...... 16.4%
2750 Sand Hill Road
Menlo Park, CA 94025
General Nutrition
Investment Company(4).... 2,947,853 ...... 6.9%
1002 South 63rd Avenue
At Buckeye
Phoenix, AZ 15222
Vulcan Ventures,
Incorporated(5).......... 2,266,289 ...... 5.3%
110 110th Avenue NE,
Suite 550
Bellevue, WA 98004
Peter M. Neupert(6)....... 1,848,146 ...... 4.3%
13920 Southeast Eastgate
Way Suite 300
Bellevue, WA 98005
Maveron Equity Partners,
L.P.(7).................. 1,184,683 ...... 2.8%
Jeffrey P. Bezos(1)....... 11,733,523 ... ... 27.4%
Brook H. Byers(3)...........7,030,771 ... ... 16.4%
L. John Doerr(3).......... 7,030,771 ... ... 16.4%
William Savoy(5).......... 2,266,289 ... ... 5.3%
Howard Schultz(7)......... 1,184,683 ... ... 2.8%
Jed A. Smith(8)........... 975,000 ... ... 2.3%
Kal Raman(9).............. 37,500 ... ... *
All directors and officers
as a group (11
persons)(10)........... 25,117,912 ... ... 58.6%
</TABLE>
--------
* Less than 1%
(1) Jeffrey P. Bezos is a director of drugstore.com and is the chairman of the board and chief executive officer of Amazon.com, Inc.
62
<PAGE>
(2) Under the terms of the Third Amended and Restated Voting Agreement dated June 17, 1999, Rite Aid will have the right to nominate one member to our board of directors.
(3) Consists of 6,313,633 shares held by Kleiner Perkins Caufield & Byers VIII, L.P. (KPCB VIII), 365,600 shares held by KPCB VIII Founders Fund, L.P., and 351,538 shares held by KPCB Life Sciences Zaibatsu Fund II, L.P.KPCB VIII and KPCB VIII Founders Fund, L.P. are wholly controlled by KPCB VIII Associates, L.P. KPCB Life Sciences Zaibatsu Fund II, L.P. is wholly controlled by KPCB VII Associates, L.P. Brook H. Byers and L. John Doerr, each a general partner of KPCB VIII Associates and KPCB VII Associates, L.P., are both directors of drugstore.com. Mr. Byers and Mr. Doerr each disclaim beneficial ownership of shares held by these entities except to the extent of his pecuniary interest in those shares.
(4) On July 5, 1999, General Nutrition Companies, Inc., the parent company of General Nutrition Investment Company, announced that it agreed to merge with Royal Numico N.V., a European maker of nutrition products.
(5) William D. Savoy is a director of drugstore.com and is the vice president of Vulcan Ventures, a venture capital firm wholly-owned by Paul Allen. Mr. Savoy disclaims beneficial ownership of shares held by Vulcan Ventures except to the extent of his pecuniary interest in those shares.
(6) As of July 16, 1999, 945,000 of such shares are subject to a right of repurchase at cost in the event Peter M. Neupert ceases to be an employee of drugstore.com. Mr. Neupert's shares of preferred stock are held jointly by Mr. Neupert and Sheryl Neupert.
(7) Howard Schultz is a director of drugstore.com and one of two founding members of Maveron LLC and is one of two members of a limited liability company that serves as a general partner of its affiliated venture capital fund, Maveron Equity Partners, L.P. Mr. Schultz disclaims beneficial ownership of shares held by these entities except to the extent of his pecuniary interest in those shares.
(8) As of July 16, 1999, 304,688 of such shares are subject to a right of repurchase at cost in the event Jed A. Smith ceases to be an employee of drugstore.com. Includes 40,000 shares held by The Jed Smith 1998 Irrevocable Trust and 15,000 shares held by family members of Mr. Smith.
(9) During 1998 and 1999, Kal Raman was granted options to purchase 225,000 shares of our common stock. As of 60 days after July 16, 1999, 37,500 of these shares were vested.
(10) Does not include shares that will be beneficially owned by Rite Aid's nominee to the board of directors since such nominee has not yet been appointed to the board. 75,000 shares subject to options held by the directors and officers are exercisable within 60 days of July 16, 1999.
63
<PAGE>
DESCRIPTION OF CAPITAL STOCK
As of July 16, 1999, there were 36,791,000 shares of common stock
outstanding. Upon completion of this offering, drugstore.com will be
authorized to issue 250,000,000 shares of common stock, $.0001 par value, and 10,000,000 shares of undesignated preferred stock, $.0001 par value
The offering of 5 million shares, plus overage allotment, will bring the total number of shares to 42 million.
Tom D
|
